MENU
+Compare
ICUI
Stock ticker: NASDAQ
AS OF
Nov 21, 04:59 PM (EDT)
Price
$142.44
Change
+$8.11 (+6.04%)
Capitalization
3.32B

ICUI ICU Medical Forecast, Technical & Fundamental Analysis

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care... Show more

ICUI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ICUI with price predictions
Nov 20, 2025

ICUI in downward trend: price expected to drop as it breaks its higher Bollinger Band on November 05, 2025

ICUI broke above its upper Bollinger Band on November 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 45 similar instances where the stock broke above the upper band. In of the 45 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ICUI moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on October 21, 2025. You may want to consider a long position or call options on ICUI as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on October 21, 2025. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

ICUI moved above its 50-day moving average on November 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ICUI crossed bullishly above the 50-day moving average on November 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 178 cases where ICUI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.559) is normal, around the industry mean (9.026). P/E Ratio (0.000) is within average values for comparable stocks, (156.260). Projected Growth (PEG Ratio) (1.615) is also within normal values, averaging (2.490). ICUI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (1.431) is also within normal values, averaging (111.085).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ICUI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ICUI is expected to report earnings to fall 15.76% to $1.71 per share on March 04

ICU Medical ICUI Stock Earnings Reports
Q4'25
Est.
$1.71
Q3'25
Beat
by $0.61
Q2'25
Beat
by $0.60
Q1'25
Beat
by $0.45
Q4'24
Beat
by $0.62
The last earnings report on November 06 showed earnings per share of $2.03, beating the estimate of $1.42. With 184.36K shares outstanding, the current market capitalization sits at 3.32B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical technologies

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
951 Calle Amanecer
Phone
+1 949 366-2183
Employees
14000
Web
https://www.icumed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAFLX15.02N/A
N/A
Lord Abbett Focused Large Cap Value A
DPWRX73.45N/A
N/A
BNY Mellon Worldwide Growth I
CSMFX24.24N/A
N/A
Carillon Scout Mid Cap C
RGBEX40.98-0.25
-0.61%
American Funds Global Balanced R4
MLVGX19.49-0.16
-0.81%
MFS Low Volatility Equity C

ICUI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+1.33%
CLPT - ICUI
57%
Loosely correlated
-3.43%
A - ICUI
50%
Loosely correlated
+0.46%
MMSI - ICUI
48%
Loosely correlated
+1.42%
RGEN - ICUI
47%
Loosely correlated
-0.46%
NVST - ICUI
47%
Loosely correlated
+0.84%
More

Groups containing ICUI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+1.33%
Pharmaceuticals: Other
industry (103 stocks)
45%
Loosely correlated
+2.14%
Pharmaceuticals
industry (378 stocks)
41%
Loosely correlated
+1.00%